C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-β production

Virology

Volumn 325, Issue 1, 2004, Pages 137-148

  Komatsu, Takayuki ^a   Takeuchi, Kenji ^a   Yokoo, Junko ^a   Gotoh, Bin ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

C protein; Interferon; IRF 3; NF B; Sendai virus; V protein

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; PROTEIN C; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN V;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SENDAI VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS INFECTION;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; DIMERIZATION; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VERO CELLS; VIRAL PROTEINS;

NEWCASTLE DISEASE VIRUS; SENDAI VIRUS;

EID: 3042615308     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.04.025     Document Type: Article

References (78)

1. Andrejeva J., Young D.F., Goodbourn S., Randall R.E. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76(5):2002;2159-2167
2. Asao H., Fu X.Y. Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation. J. Biol. Chem. 275(2):2000;867-874
3. Au W.C., Yeow W.S., Pitha P.M. Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology. 280(2):2001;273-282
4. Basler C.F., Wang X., Muhlberger E., Volchkov V., Paragas J., Klenk H.D., Garcia-Sastre A., Palese P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. U.S.A. 97(22):2000;12289-12294
5. Cadd T., Garcin D., Tapparel C., Itoh M., Homma M., Roux L., Curran J., Kolakofsky D. The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J. Virol. 70(8):1996;5067-5074
6. Chu W.M., Ostertag D., Li Z.W., Chang L., Chen Y., Hu Y., Williams B., Perrault J., Karin M. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity. 11(6):1999;721-731
7. Curran J., Kolakofsky D. Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo. EMBO J. 8(2):1989;521-526
8. Curran J., Marq J.B., Kolakofsky D. The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology. 189(2):1992;647-656
9. Delenda C., Taylor G., Hausmann S., Garcin D., Kolakofsky D. Sendai viruses with altered P, V, and W protein expression. Virology. 242(2):1998;327-337
10. Didcock L., Young D.F., Goodbourn S., Randall R.E. Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J. Virol. 73(4):1999;3125-3133
11. Didcock L., Young D.F., Goodbourn S., Randall R.E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73(12):1999;9928-9933
12. Du W., Maniatis T. An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected]. Proc. Natl. Acad. Sci. U.S.A. 89(6):1992;2150-2154
13. Du W., Thanos D., Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell. 74(5):1993;887-898
14. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4(5):2003;491-496
15. Garcia-Sastre A. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology. 279(2):2001;375-384
16. Garcin D., Latorre P., Kolakofsky D. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73(8):1999;6559-6565
17. Garcin D., Curran J., Itoh M., Kolakofsky D. Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J. Virol. 75(15):2001;6800-6807
18. Giorgi C., Blumberg B.M., Kolakofsky D. Sendai virus contains overlapping genes expressed from a single mRNA. Cell. 35(3 Pt. 2):1983;829-836
19. Goodbourn S., Didcock L., Randall R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81(Pt. 10):2000;2341-2364
20. Gotoh B., Ohnishi Y., Inocencio N.M., Esaki E., Nakayama K., Barr P.J., Thomas G., Nagai Y. Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J. Virol. 66(11):1992;6391-6397
21. Gotoh B., Takeuchi K., Komatsu T., Yokoo J., Kimura Y., Kurotani A., Kato A., Nagai Y. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett. 459(2):1999;205-210
22. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 45(12):2001;787-800
23. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramyxovirus strategies for evading the interferon response. Rev. Med. Virol. 12(6):2002;337-357
24. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology. 316(1):2003;29-40
25. Gotoh B., Takeuchi K., Komatsu T., Yokoo J. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J. Virol. 77(6):2003;3360-3370
26. Hasan M.K., Kato A., Muranaka M., Yamaguchi R., Sakai Y., Hatano I., Tashiro M., Nagai Y. Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role. J. Virol. 74(12):2000;5619-5628
27. He B., Paterson R.G., Stock N., Durbin J.E., Durbin R.K., Goodbourn S., Randall R.E., Lamb R.A. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology. 303(1):2002;15-32
28. Heylbroeck C., Balachandran S., Servant M.J., DeLuca C., Barber G.N., Lin R., Hiscott J. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J. Virol. 74(8):2000;3781-3792
29. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77(1):1989;51-59
30. Huang Z., Krishnamurthy S., Panda A., Samal S.K. Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J. Virol. 77(16):2003;8676-8685
31. Iordanov M.S., Paranjape J.M., Zhou A., Wong J., Williams B.R., Meurs E.F., Silverman R.H., Magun B.E. Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell. Biol. 20(2):2000;617-627
32. Iwamura T., Yoneyama M., Yamaguchi K., Suhara W., Mori W., Shiota K., Okabe Y., Namiki H., Fujita T. Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells. 6(4):2001;375-388
33. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:2000;621-663
34. Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16(3):1997;578-587
35. Kato A., Kiyotani K., Sakai Y., Yoshida T., Shioda T., Nagai Y. Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71(10):1997;7266-7272
36. Kato A., Ohnishi Y., Kohase M., Saito S., Tashiro M., Nagai Y. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J. Virol. 75(8):2001;3802-3810
37. Kato A., Ohnishi Y., Hishiyama M., Kohase M., Saito S., Tashiro M., Nagai Y. The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis. J. Virol. 76(14):2002;7114-7124
38. King P., Goodbourn S. The beta-interferon promoter responds to priming through multiple independent regulatory elements. J. Biol. Chem. 269(48):1994;30609-30615
39. Komatsu T., Takeuchi K., Yokoo J., Tanaka Y., Gotoh B. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. J. Virol. 74(5):2000;2477-2480
40. Komatsu T., Takeuchi K., Yokoo J., Gotoh B. Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett. 511(1-3):2002;139-144
41. Koyama A.H., Irie H., Kato A., Nagai Y., Adachi A. Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins. Microb. Infect. 5(5):2003;373-378
42. Kubota T., Yokosawa N., Yokota S., Fujii N. C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem. Biophys. Res. Commun. 283(1):2001;255-259
43. Kurotani A., Kiyotani K., Kato A., Shioda T., Sakai Y., Mizumoto K., Yoshida T., Nagai Y. Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells. 3(2):1998;111-124
44. Latorre P., Cadd T., Itoh M., Curran J., Kolakofsky D. The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection. J. Virol. 72(7):1998;5984-5993
45. Lenardo M.J., Fan C.M., Maniatis T., Baltimore D. The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell. 57(2):1989;287-294
46. Lin R., Heylbroeck C., Pitha P.M., Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18(5):1998;2986-2996
47. Lin R., Genin P., Mamane Y., Sgarbanti M., Battistini A., Harrington W.J. Jr., Barber G.N., Hiscott J. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene. 20(7):2001;800-811
48. Maniatis T., Falvo J.V., Kim T.H., Kim T.K., Lin C.H., Parekh B.S., Wathelet M.G. Structure and function of the interferon-beta enhanceosome. Cold Spring Harbor Symp. Quant. Biol. 63:1998;609-620
49. Naniche D., Yeh A., Eto D., Manchester M., Friedman R.M., Oldstone M.B. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J. Virol. 74(16):2000;7478-7484
50. Nishio M., Tsurudome M., Ito M., Kawano M., Komada H., Ito Y. High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich v-specific domain is required for high resistance to the interferons. J. Virol. 75(19):2001;9165-9176
51. Palosaari H., Parisien J.P., Rodriguez J.J., Ulane C.M., Horvath C.M. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77(13):2003;7635-7644
52. Parisien J.P., Lau J.F., Rodriguez J.J., Sullivan B.M., Moscona A., Parks G.D., Lamb R.A., Horvath C.M. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology. 283(2):2001;230-239
53. Park M.S., Shaw M.L., Munoz-Jordan J., Cros J.F., Nakaya T., Bouvier N., Palese P., Garcia-Sastre A., Basler C.F. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77(2):2003;1501-1511
54. Poole E., He B., Lamb R.A., Randall R.E., Goodbourn S. The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology. 303(1):2002;33-46
55. Rodriguez J.J., Parisien J.P., Horvath C.M. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76(22):2002;11476-11483
56. Rodriguez J.J., Wang L.F., Horvath C.M. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J. Virol. 77(21):2003;11842-11845
57. Ronco L.V., Karpova A.Y., Vidal M., Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12(13):1998;2061-2072
58. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441(1):1998;106-110
59. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 13(4):2000;539-548
60. Schafer S.L., Lin R., Moore P.A., Hiscott J., Pitha P.M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273(5):1998;2714-2720
61. Servant M.J., Grandvaux N., Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharmacol. 64(5-6):2002;985-992
62. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science. 300(5622):2003;1148-1151
63. Shioda T., Hidaka Y., Kanda T., Shibuta H., Nomoto A., Iwasaki K. Sequence of 3687 nucleotides from the 3′ end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res. 11(21):1983;7317-7330
64. Strahle L., Garcin D., Le Mercier P., Schlaak J.F., Kolakofsky D. Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner. J. Virol. 77(14):2003;7903-7913
65. Suhara W., Yoneyama M., Iwamura T., Yoshimura S., Tamura K., Namiki H., Aimoto S., Fujita T. Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300. J. Biochem. (Tokyo). 128(2):2000;301-307
66. Takeuchi K., Komatsu T., Yokoo J., Kato A., Shioda T., Nagai Y., Gotoh B. Sendai virus C protein physically associates with Stat1. Genes Cells. 6(6):2001;545-557
67. Takeuchi K., Kadota S.I., Takeda M., Miyajima N., Nagata K. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 545(2-3):2003;177-182
68. Talon J., Horvath C.M., Polley R., Basler C.F., Muster T., Palese P., Garcia-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74(17):2000;7989-7996
69. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:2001;623-655
70. Tapparel C., Hausmann S., Pelet T., Curran J., Kolakofsky D., Roux L. Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J. Virol. 71(12):1997;9588-9599
71. Visvanathan K.V., Goodbourn S. Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO J. 8(4):1989;1129-1138
72. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell. 1(4):1998;507-518
73. Weaver B.K., Kumar K.P., Reich N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18(3):1998;1359-1368
74. Yokoo J., Gotoh B., Komatsu T., Takeuchi K., Miyadai T. Replication-incompetent Sendai virus can suppress the antiviral action of type I interferon. Arch. Virol. 144(6):1999;1043-1055
75. Yokota S., Saito H., Kubota T., Yokosawa N., Amano K., Fujii N. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex. Virology. 306(1):2003;135-146
76. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17(4):1998;1087-1095
77. Yoneyama M., Suhara W., Fujita T. Control of IRF-3 activation by phosphorylation. J. Interferon Cytokine Res. 22(1):2002;73-76
78. Young D.F., Didcock L., Goodbourn S., Randall R.E. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology. 269(2):2000;383-390